Chemoinformaics analysis of 13(16),14-Labdien-8-ol
| Molecular Weight | 224.344 | nRot | 3 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 30 |
| Exact Molecular Weight | 224.178 | nRing | 1 |
| Solubility: LogS | -2.779 | nHRing | 0 |
| Solubility: LogP | -1.806 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 40.987 |
| nHD | 2 | BPOL | 24.077 |
| QED | 0.147 |
| Synth | 4.854 |
| Natural Product Likeliness | 1.517 |
| NR-PPAR-gamma | 0.908 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.963 |
| HIA | 0.988 |
| CACO-2 | -6.398 |
| MDCK | 0.0000708 |
| BBB | 0.264 |
| PPB | 0.772609 |
| VDSS | 0.866 |
| FU | 0.176312 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.266 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.125 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.001 |
| CL | 1.267 |
| T12 | 0.297 |
| hERG | 0.036 |
| Ames | 0.339 |
| ROA | 0.47 |
| SkinSen | 0.035 |
| Carcinogencity | 0.033 |
| EI | 0.003 |
| Respiratory | 0.008 |
| NR-Aromatase | 0.907 |
| Antiviral | Yes |
| Prediction | 0.841056 |